An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Eli Lilly
- 28 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 28 Jul 2009 Actual patient number (151) added as reported by ClinicalTrials.gov.
- 28 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.